Analysis of cancer patient data for research purposes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects and analyzes electronic health record data from cancer patients to address various research questions and generate real-world insights. It is a multisite, minimal risk study that utilizes existing medical records as part of standard care, allowing for the creation of robust data sets without requiring additional interventions. The goal is to enhance understanding of cancer treatment and outcomes through cohort-based research.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subjects must be diagnosed with cancer
* Medical records available to meet cohort requirements

Exclusion Criteria:

- None

Where it's running

• Memorial Health Services
  Fountain Valley, California, United States Recruiting
• Cancer Specialists of Northern Florida
  Jacksonville, Florida, United States Recruiting
• Hawaii Cancer Care
  Honolulu, Hawaii, United States Recruiting
• Illinois Cancer Care
  Peoria, Illinois, United States Recruiting
• Northwest Oncology and Hematology
  Rolling Meadows, Illinois, United States Recruiting
• Community Health Network
  Indianapolis, Indiana, United States Recruiting

Study contacts

• Study coordinator: Lauren Lopez
• Email: polaris@tempus.com
• Phone: tel:8007394137

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tempus Open Link registry for cancer patients using Olivia platform

  This registry tests whether Olivia can securely enroll cancer patients and combine their health data from EHRs and patient-reported outcomes to build a large, de-identified dataset.

  Recruiting Tempus AI · Chicago, Illinois · NCT07756034

• Using blood-based tumor DNA (ctDNA) to find leftover breast cancer after treatment

  This research will test whether a simple blood test that looks for tiny bits of tumor DNA can tell if people treated for breast cancer (including HR+/HER2-, HER2+, and triple-negative) still have leftover cancer or are at risk of recurrence.

  Recruiting at 16 sites Tempus AI · Birmingham, Alabama and 15 other locations · NCT07211178

• Longitudinal multi-center molecular biomarker registry for blood cancers

  This registry will collect serial blood samples and leftover tissue from people with AML or follicular lymphoma to see if molecular biomarkers predict disease course and treatment outcomes.

  Recruiting at 13 sites Tempus AI · Iowa City, Iowa and 12 other locations · NCT07154823

• AI-analyzed ECG to help find pulmonary hypertension in people with interstitial lung disease

  This project tests whether an AI-read 12-lead ECG can help doctors find hidden pulmonary hypertension in adults with interstitial lung disease.

  Recruiting at 41 sites Tempus AI · Birmingham, Alabama and 40 other locations · NCT06911632

• A biobank registry platform for cancer patients

  This study is testing how blood samples from cancer patients can help researchers learn more about tumor DNA and improve cancer treatments.

  Recruiting at 25 sites Tempus AI · Birmingham, Alabama and 31 other locations · NCT06207032

• Longitudinal biomarker profiling for patients with head and neck cancer

  This study is trying to see how the molecular makeup of head and neck cancer changes over time in patients who are receiving first-line anti-PD1 or PDL1 therapy.

  Recruiting at 31 sites Tempus AI · Duarte, California and 31 other locations · NCT06163534

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.